Topic: Liver Diseases

Bristol-Myers liver cancer drug fails trial

(Reuters) - Bristol-Myers Squibb Co said on Thursday its liver cancer drug brivanib failed to meet the primary endpoint in a late-stage clinical trial.Brivanib failed to meet the main goal of improving overall survival versus placebo in liver cancer patients who failed ...

Bristol-Myers, J&J team up against hepatitis C

NEW YORK (Reuters) - Bristol-Myers Squibb Co and Johnson & Johnson plan to jointly develop experimental treatments for hepatitis C in a market worth billions of dollars.The drugs being developed by the two companies work by blocking different proteins than those attacked ...

China clinic blamed for hepatitis C outbreak

More than 150 Chinese villagers, many of them children, may have been infected with hepatitis C by a clinic that reused old needles, state media and local authorities said Wednesday.Nineteen people who received treatment at the privately-run clinic in central China have ...

Gilead bets $11 billion on hepatitis in Pharmasset deal

(Reuters) - Gilead Sciences Inc struck a deal to buy biotechnology company Pharmasset Inc for about $11 billion in a huge and risky bet on the next generation of hepatitis C treatments.Gilead, the world's largest maker of HIV drugs, will pay $137 ...

Gilead to buy biotech Pharmasset for $11 billion

(Reuters) - Gilead Sciences Inc struck a deal to buy biotechnology company Pharmasset Inc for about $11 billion in a huge bet on the next generation of hepatitis C treatments.Gilead, the world's largest maker of HIV drugs, will pay $137 per share ...

Gilead to buy Pharmasset for $11 billion

(Reuters) - Gilead Sciences Inc struck a deal to buy Pharmasset Inc for about $11 billion in a huge bet on hepatitis C treatments to diversify its portfolio.Gilead, the world's largest maker of HIV drugs, will pay $137 per share for each ...

Pioneering liver treatment cures baby

Doctors said they had cured a baby boy of a life-threatening liver disease using a pioneering treatment in which cells are injected into the abdomen.The team from London's King's College Hospital treated eight-month old Iyaad Syed by injecting him with a group ...

Pioneering liver treatment cures British baby

British doctors said they had cured a baby boy of a life-threatening liver disease using a pioneering treatment in which cells are injected into the abdomen.The team from London's King's College Hospital treated eight-month old Iyaad Syed by injecting him with a ...

Ali among many pulling for gravely ill Frazier

Former world heavyweight champion Joe Frazier, battling advanced liver cancer, is in the prayers of his most famous rival -- Muhammad Ali."The news about Joe is hard to believe and even harder to accept," Ali, who fought a famed trilogy of bouts ...

Pharmasset starts late-stage trial of hep C drug

(Reuters) - Pharmasset Inc said it started a late-stage trial of its experimental hepatitis C drug, sending the pharmaceutical company's shares up as much as 12 percent.The study will seek to ascertain whether the drug, PSI-7977, taken orally along with ribavirin -- ...
Previous